THE FRIENDS OF BRISTOL HAEMATOLOGY ANO ONCOLOGY CENTRE ANNUAL REPORT AND AUDITED FINANCIAL STATEMENTS YEAR ENDED 31 DECEMBER 21123 Charlty No 264136
THE FRIENDS OF BRISTOL HAEMATOLOGY AND ONCOLOGY CENTRE ANNUAL REPORT AND FINANCIAL STATEMENTS YEAR ENDED 31 DECEMBER 2023 The Tru* was eslablishgd under a tnjsl deed In April 1972 In order to provid8 mli8f to patients at the centre and to support thè work of th ntre. The Trust Is a register¢d charty. Pro$id8nt: The Lord Mar of 8ri8tol Offieèrs Chalr G•nèral S•Gr•tary Tm#ur•r Mrs O Grogono Mrs E Pfitchard Mts CM Owen TTU$tee5 IAr S Blake Mr8 A Cartton Mr GJ Clements Mrs L Oensharn Mr8 G Creese Dr G Crichton Mrs N Day Mrs O Grogono Mrs J Lockwood Mr S Moorlen Mrs P Murphy Mrs CM Owen Mrs S Sims Mrs A Thomas Bankèrs NatSonal Westfflinster Bank plc Bristol City Offica Audrto Elllott Bunker Lirnited 1st Floor 61 P418crae Road Ham Gr8en Bristol BS20 ODD Stock brtrkers pha Portfolio Management 1 Tha Square Tme Quay Bristol Reiistered Offko Brkstol Haemabl(yay and onlogY Centre Horfield Road Brt01 0117 342 3432 Telephone Pagg 1
THE FRIENDS OF BRISTOL HAEMATOLOGY AND ONCOLOGY CENTRE ANNUAL REPORT AND FINANCIAL STATEMENTS YEAR ENDED 31 DECEMBER 2023 Tru5te•$' roport The trust68s wèsent thoir report and Ihe audltod financial statements for th8 year 8ndad 31 Deeèmbar 2023. The linancEal statements have been prepared in accordance wtth the Statement of Recommended Practice: Accounting and Reportlll9 by Charities preparty their accounts in accordance wlth the Finanual Reporting Sta18[& applicabl8 in the UK and Republic of Irdand IFRS1021 and thè Financial Reporting Standard 8pplle8ble in the United KFngdom and Republsc of Ire18nd IFRS102} and the Charit$ Act 2011 and UK Ganèraly A¢¢epted Practica as it appltes from 1 J8IIU8ry 2015 Constitution and objects Thg Trust was constitut8d under the mod81 deed for Friends of Hospitals. A revised constitution was adopted in September 2(M)6. The prinapal obiect of the Trust a$ set out in thp constllutil is to offer relief to paIntS and former patients and lo support thè work of thg Centre. During the year, the charitys main objectives continued to be Ihose of fundr8ising and m8nagement of th8 invéslment portfob'o, enafrAiThJ flnancial supw>rt to be given to the Brfstol Haematdogy and Oneol(w Centre in reSpt of speclfic projects. The trust688 confimi that th8y hav8 referred to the guidance contained in the Charliy Commissloners, general guidance on Publ bertefil when reviewing Ihe Trust's aims and objeclves and in planning lutufe funding of the Cèrbtrè. struetur• and organlzatlo Thé Trust is unincorporal8d and is a registered charity. The l¥usiees kn offlce during the year and at th& dotg of thkg rgport are 8S 8el out on page 1. A main commTrttee as set out IFF the (x)nstiIul manages the Twst. Meetings are held quarterty iand are attended by FepTesenta'v8s from thg h05Pital. TFustees are invited to join the committee by existing trustees or by recommendations from hospitsl Staff. In additv)n to the main committee there is an investment commitle& which has rèsponslbllty for inv8lng the Trust's r8serve5. The inv&stment commirte8 is thairad by Mr8 O Grogono. Th& followlng trustees also seNe on eommittÈe: Mr GJ Clements. and Mrs CM Owen. Revlèw of activities and future develownents DuTlng the year th& Trust has ¢orttinued to raise money to benefft the patients of The Bristol Ha8rn8tology 8nd Oncdogy Centre. The lundrdising is 5argely i%rried out by volunteers and th• trustees are very gr816(ul to thè many volunteers who carried out fund rai8tng activities on behalf of the Trvsl during the yeat. The Trust has, and will contlnue to. support the work of the h05pilal by financlng various capital and rgs8arch proj8cts undertaken by the howtal and Br&8tol University. Flnaneial activllles and affairs There have been no eh8nges in thè polKTe8 ofthe Twst during the year. During the year IncomltvJ resources from fundr8ising, donations and legacies and investment IN(x)me tota118d £221,48712022.' £300,712, and èxpènditure on spwfic projects amouTrted to £140,278 12022.. £110,939). After dedtIng the charivs operating expenses and allowing for thg reallsed and unrealised Invastmènl rgv8luatiw suru88$ the rgsultiThJ surplus lor the yoar wos £252.175 {2022..defi(xl £243,559). At the year end the Tfust's balanc $hg¥1 SP1811 totsl lund8 of £5,356,70212022'. £5,104,527> of whSch £5.309,814 12022.. £5,054,3961 were unrestrfcted funds. Pagè 2
THE FRIENDS OF BRISTOL HAEMATOLOGY AND ONCOLOGY CENTRE
ANNUAL REPORT AND FINANCIAL STATEMENTS
YEAR ENOED 31 DECEMBER 2023
R•8rves
The unrestFiCted fund represents the 8c(yJmulated surpluses from ptevious years. The 1¢Y of tha Trust is to build these res8rves by
jUdu$ man8gemenl of investment assets to maximise th& in¢orne available for futurè years. The expenditure on charitable objectives
each year depertds on the requests from Ihe hospital man8gement. Wl expenditure is approved by the hospital managernent bOre being
presented to the fNstses al quart8rly meetings. The level of reserves is r8wewed at the meetings and decFsions regarding expenditure is
made by the Trustees h&wng given consideration to available reseeS and funds already cornmitted. The TriJst8es keep sufficitnt reserves
to support any long term commitments to the hospital. Surplus Teserves have been Inves to Mmise inc
INDEPENDENT AUDrroR'S REPORT TO THE TRUSTEES OF THE FRIENDS OF BRISTOL HAEMATOLOGY AND ONCOLOGY CENTRE Oplnlon We have audited the financi81 statements of The Friends ol Bristd Haematology and Oncology Centfe Ithe"ChariWI for the year ended 31 December 2023 which comprise the Statement ol FinAnaal Activities. Balance Sheet. Statement of Cash Flows and notes to the finandal ststements. including a sumrnary ofsignificanl 8ccounting polity6s. Th& financial reFK)rtlng framework that has been applied in thelr preparatlon is appllcable law and United lQngdom Aw)unttng Stand8rds, including Financial RepoFting Standard 102". Th8 Financial Reporting Standard appliCae in Ihe UK and Republic of Ireland IUnrt8d Kingdom Generally Accepted Accounting PraCte). In our opinion. th8 financial slatemests-. ' glve a true and fair view of the 5t8tg of th8 Chariil$ aflalrs as at 31 Dmber 2023 and of its Incomo and expendbturè for the year t and6d', . ha been prop8rly pr8pared in 8ccord8nce wrfh United Kingdom G8n6r8lly AetOPted Acwunthng Prathce. . hav8 beon prared in arrnrd8nc8 th8 r8quirements of the Charities Act 2011. Basis fr•r oplnlon Wo conducted our audit irj attordance vmth Inlem8bon81 Siandards on AudTrting {UKI IISAS IUKII 8nd applicMble18w. Our rèspon3iblilies undar those standards are further described in the Auditor's responsibilities for Ihe audit of the fin8nci81 ststeriignl$ section of ovr report. We are IrKlependent of the Charlty In accoidance with the ethical requirements that are r8Jevanl lo our audit of the financial stalements in thg VK, Induding th8 FRC'S Ethi1 Standard, and wa have fulfilled our olh•r ethical reswnslbllttles In accordance with these requlremènts. We bdieve that the aydf( eviden¢9 wtr ha obtainod 1$ suffi¢lont and ¥pproprlgte to prod8 a basi5 lor our oplnion. Concluslons rÈlatlng to golng concern We have nothlng to report In respect of the flng matters tn relatbn to which tt)e ISAS {UKI requke us to report to you where.. . the twstees, use of the going concem basis of accounting in the preparallon of the financlal slaternents is nol appropriate.. or •the trvslees have nDt disd08ed in th8 finanri$l Statements any identif18d molerial uneertainlies that may ¢a$l $&Jnifieant doubt abtsul Ihe Charrtls abllilyto continue to adopt the going ncern bas¢3 ol accounting for 8 period of atloast twelve months from the date ¥then the finanoal statamentg arè authorised for issue. Othèr Inforni•tlon Th8 InJslee5 are resnsible for the other information. The olher informatK)n comprises th8 infoTmatKM included in the annu81 r8POrt other than the finaniaal statements and our auditorfs report thereon. Our opinion on the financial statements does not cover the other InfOatIOn and, except to the extent otherwise eXplicY stated in our rewt. wa do not express any fomi of assurance condusion thereon. In connecllon our audit of the financial staternenls, our responslbnity is to read the other information and. in doing so, consider whether tho oth8r InIrnatIon Is materfally Inconslstent wlth Ihe flnancl81 statèm&ntS Of our kned9È obt8in611 In the audlt Or ot178tWig6 appears to be m8teri811y misststed. If we 4dentify suth rn8t8rlÈl inconsist9ncies or app3r8nt rnateri81 rnissla18ments, we 818 r9qUtr8d to dfjtermine whether there is a material misslalement in the financial statements or a material misstalement of the other inlomalion. If, based on Ihe we have perfomied, we conclude that there is a material misstatement of this other infomation, we are wuired to rep)rt that fact. We have nothing lo rety)rt in thls ieg8rd. Matters on whl¢h wg aro rgqulrgd to r¢port by gxcgpllon In the light of the knoedge and understanding of the Charity and ils environment obtained in the course of the audit. we have not identthed material misstatements In the TnJsteÈs' Annual Report. Page 4
We have nolhing to r8port in resCl ol the fdloW9 matters in ratTrn to which tho Charitl&s Act 2011 raquires us to report to you rf, in OUT opinn.. . SUff18t accounting recorfls have not been kept. the financsal statern8rnts are not in agreement wilh the acwunung records and returns. or . have not oblained all Ihe inlomi8tion explanatson5 necessaryfor the purposes of our audit. Responslblllttos of the tru5te8s As 8xp58ined more fvlly in the trustees. responsibdeS statement set out on page 3. the trustees are iesponsible fDr the preparation of the financial statements arKI for being satisfied that they give a true and fair yiew, and for such inlemal contrd as they determine is n8ce&%ary to en818 th8 preparation of financial statements that are freg from Materi mState[lIent. vJh9ther due lo fraud or error. In preparing the ffinancial st8t&menis, the trusteas are responsible for assessing the Charivs abilty to continue as 8 golng concem. dlsclosing. as applicable, mattels rèlated to going coNM and usirvJ the going concern basis of 8ceountlng unless the IDJStees either int8nd to Ilquidate ihe Charfty or to C8858 operations, or have no reali*ic altematlve but to do so. Our resp0nslb151t1 for thè audit of the flnaneSal statements Kèy audlt matters: our assessmont of risks of mat8rlal ml$sfatement Kéy audit matters are those rnatters that in our profossional judgement were of m05t signfficanco in the audlt ol ihe fin8ndal stslernents and in¢ludè the most significant assessed rfsks of material misstatement (whèther or not du8 to fraud) identtfied by us, Induding those which had tho greatest effect on the allocalion of fesources in the audit, and direding the efforts of the engagement tèam. There aro no key area5 identified as the audit IS Very low iisk wth nomal audit procedures adequate in all audit areas. We agreed to report to ihe board ol trustees any correcled OT unc0cted Sdentified misstslements Identifying and reportlng al rlsks of materfal mlsstat•ment duo to fraud To len risks of ¥n8tèrial misslatoment due lo fraud we assess8d avents or conditions that could indicate an irsc¥ntN8 or pressur8 to commit fr8ud or prowde 8n opportunity to commit fraud. Our risk assessment procedur98 inc1ed. 111 enquirin9 of the truste85 and inspection ol key papers promded to ihose eharged with gov8mance as to high level Oi¢ies and proceduFes to pravenl and detect frBud. lill reviewg the minutes of trustses, meetings. We communicated identthed fraud risks through1 tho audit team and femained alert to any indic8tK)ns of Iraud throughoul the audit. AS wulrad by Auditing Standards, and taking into aceourt OUT overAII knowledge of tha contrd environment, w8 perfomed t0dreS to assess the risks of management overrfdè of controls. To address the pervaslve risk as it felated to management override of controls. we revEwed material journ entrfes and agre811 these to supportlng documentath)n where 8PPtopnate. Identlfylng and r•sponding to rfsk¥ of mat•rlal mlsstat•mont du• to nonwcompllancè wlth laws and r•gulatitsn8 We idèntified areas of laws and re9ulab.ons that could reasonaiAy b8 Èxpected to have a rnaterial effect on the financial statements from our general commerual and sector experience and through dK%(#Jssion wth the Treasur8r. As the charity Is regulated. our assessrnent of risks invdved gaining an undetstanding of th8 wntrol environment Induding the entiils procedures for cornplng wth regulatory requiremenis. P8ge 5
We communicated identFfied laws and regulatlons throughout our team and r8rnain8d alert lo any indlcatlons of non-compliance IhroUghJt the audit. Auditing starards limit Ihe required audit procedures to identify noTrcompli8nce with these laws and Tegulations tts enquiry of management arKI trustees 8fKI inspection ol regulatory and legal eO$pOndenCe, rf any. Th8r81ore, if any breach of operational regulations is not disdosed to us or evldent from relevant corresponden¢%. an 8udil will not detect that breach. Llmltstlon5 to th• ablllty of th• audlt to dètect fraud OT breaches of laws and r•gulatlon Owing to the Inherent limitation of 8n audit, there is an unaVoidae risk that we may not h8V8 dtted some material tnisstaternents in the nancial statement5. even though we have properfy planned Bnd perfomed our audit in accordance wth auditing standards. For eXarne, the fvrther r8rnoved nOrCoMplIance with laws and regulations is from the 8vents and transactions reftected In th8 financial statements, the less likely the Inher6ndy Ilmtted proceduras roqulred by Audibng Standard5 would hlentify it. In addibon, as s%ith any8udit. there remained a hpher rlsk of non-detectK)n of Ir8ud, as this may Thivolv8 tolusion, forgery, intenlh)nal omissK)ns. mlsrepre5entations. th6 overilde of internal ntrol5. Our audit procedures a desioned to detect material misstataTll8nl, and therefore we are noi spOr}SIble for prevtrntin9 non-compliance or fraud and canno( be expected to detect non-compliance with 8Jl laws and regulatiDns. A further d8scripllon ot our responslbllitias for the audil of the financial statements is knatod on fho Financ¥al RepA)rting CtyJrtil's website al.. ww.frc.ug.ukJaudltoYsrosponslbllitsè5. This descrfpt¢on lom)s part of otsr auditorfs r8P(Wt. U¥e ol our report This report is made sdely lo the Charitvs trustees. ?$ a b(Kly. In awjrdance wlth section 144 of the Chaiiugs Acl 2011 and thè regul8tior made under section 154 01 that Act. Our audit WOFk has been underlaken so that we mtqhl st8te to the Charitys trustees those m8tt8rs we are required to state to them in an auditorfs r8tK)rt and for no other purpose. To the full85t 8xtent pelmitled by law, we do not a8p1 or assume responsibillty to anyone other than thg Chariiys trustees as a body, for audlt woik. for this report, or for the opinions we have fomied. P8uI Cridland Elltt 8unker Ltd (Chartered AcciMJnt8nts and Stsiulory Auditor) 1 Floor, 61 Ma¢rae Road Eden Business Park Ham Green Bristol BS20 ODO Date 21 201* P8w6
THE FRIENDS OF BRISTOL HAEMATOLOGY AND ONCOLOGY CEKfRE STATEMENT OF FINANGIALACTMTIES YEAR ENDED 31 DECEMBER 2023 2023 Unre6trICt R8strlct fund fvnds 2022 Restrlet•d funds Total Unr•strl¢ted fund Total Note Income and endowments from Don8tions and leyaeies Othef trading actilIeS Investment Inrne 83,111 2,836 108,537 26,718 109,829 2.836 108.822 136,299 37,066 98,027 29,2S8 165.557 37.066 98,089 285 Total 194,484 27,003 221,487 271,392 29.320 3(X).712 Expenditure on Raisiry funds Charitst4e 8¢1ivlbes 2,263 184.070 17,997 90.914 17,997 152.706 86,556 97,514 61.792 Tolal 88,819 97,514 186.333 108.911 61.792 170,703 Net income 105.865 170,5111 35,154 162.481 (32,4721 130,009 Trdnsfers Gross transfefs between lunds Net incorne befe other r8cognised gains and losses 167,2681 67,268 132.2461 32.246 38.397 13.2431 35,154 130,235 1226) 130.CK19 OTHER RECOGNISED GAINS ILos88sygains on inv8stments R6dised 98ins on diswsals Unallsd gam1{k)Ssesl on aluations 83,313 83.313 220.678 220,678 133.708 133,708 1594,246) 1594,246) Net movement In furKI 255.418 13,2431 252.175 243.3331 12261 1243,559) Total funds brought forward 5.054,396 50.131 5.104.527 5,297.729 50,357 5,348.086 Total funds carri•d forward 5,309,814 46,888 5,356,702 5.05S.396 50,131 5,104,527 All actiwiÉes relate to continuinu operath)ns. galns and k)sses r8cognk8ed in the year are Indud9d in the Statement of Finonc481 Activities. Pago 7
THE FIIENDS OF BRISTOL HAEMATOLOGY AND ONCOLOGY CEKfRE BALANCE SHEET YEAR ENDED 31 DECEMBER 2023 Notè 2023 2022 FIXED ASSETS Investments 4.603.040 4,411.702 CURRENT ASS3 Debtors 10 1.549 759.$41 761,190 30,0 672.005 702,005 Cash at bank and hand CREDITORS: amounts falllng due wlthln one 7,528 9,180 Nel ¢urrent assets 753,662 692.825 Totsl a88•ts less current Ilabllltles 5.356.702 5,104,527 Fund$ Unrestrted fund 12 5,309.814 46,888 5,054.3 50.131 Restricted fund 5,356.702 5,104,527 Approved and authoris8d for i5SUg by th8 Trustees on I .1 Is12 and sIg on Ihdr behalf by Mrs O Grogono- Chair The rK)t6s on pages 10 to 15 fomi an intggral part of thèse acwunts. Poge 8
THE FRIENDS OF BRISTOL HAEMATOLOGY AND ONCOLOGY CENTRE STATEMENT OF CASH FLOW YEAR ENDED 31 DECEMBER 2023 Total Funds 2023 Total Funds 2022 Net ¢a5h g•MYated by oporattng a¢tiviilÈs 15 {46,8691 997 Cash from investing aetwities IntgrgSt and dividends Tn$fer from stockbroker 108,822 25,683 98.089 25,728 Cash provbd•d by invÈstin9 activities 134,505 123,817 Change In cash •nd eash equivalent¥ In the yoar 87.636 124,814 Cash and cash oquivalents brought forward 672,005 547,191 C•5h and cash equival•nts caffièd forward 759.641 672,005 P896 9
THE FRIENDS OF BRISTOL HAEMAfoLOGY AND ONCOLOGY CENTrE NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2023 Accountlng poliei•8 Basis of prep8raf¥)n 8nd s83Ment of golng coneem The finanal statemenls have begn prepared under th8 historical cost corwenlion. as rTM)dified by the revaluation of certain fixed assets, and in accordance with the Slalemenl of Recommended Pr8ct%ce 'Accountlllg 8nd Reporting by Ch8rthes prep8r5ng their accounts i accordance with Financial Reporting Standard applIble in the UK and Republi¢ of Ir91and' IFRS1021, 8ppIiG8ble ac(thnting standards and the Ch&rities Act 2011. Thg Ttust COn5titut8s a publlc benefit entity as defined by FRS102. Ineomlng resoufces DonatNin8 ar8 accountéd for when r&c6ived by Ihe Trust and lagactos are rerA)gnised when it i8 probable thal they wll be rec£ived. Other irbcome is accwrted for on an accruals basis 85 far as il is prudent to do so. Incom& includtss incom8 tax recoverable. Roourc èxp•ndad Liabilitth are recognise( as soon as there Is a legal C4)nstnt1ve oNigation commiltln9 the charity to the expenditure. All ewendlture Is accounl6d lor on an accruals basis and has been ClarIed under headings that aggregat8 all costs related lo the category. charita expendliure comprisas those costs incunBd by the charity in Ihe dolfvery of its actlvities and 5eNIc65 for Its beneficiaries. It indud8s both CA)Sts that can b8 dir8Ctty alloc3t8d to Ihe actwity arml indlrect costs required to support the work (rf th8 tharlty. Glfts In klnd The Trust rs4Ve5 the benefft ol work carried out by vdunte8r3 8rKI is allocated 8 room at the Cgntre frge of clwge. No value 18 p¢8 on those Items. Taxatlon As a registered ch8rity. the trust is éxèmpt from tax #s IL h8s no laxaL4& 8clivsl. Irrècov6rÈbl8 VAT L¥Jrn8 by tha Trust IS Fndud8d In thè Cost th the item to whith il rel8t¥$. Investments Investment ts)come Is taken Into account on the basls of the due dale ol payment. Investsnents are a lorm of basic financlal knslmment and are initially reciyJnised at their transaclion value and subsequenuy measured at their lair value as at the balance sheet date using the dosing qlloted market price. All gains and losses, whether realised or unrealised are credited or charged to the Unrestricted Fund. Fund a¢untIng Unrestricted in¢om& tund$ ar8 9Or$I fvnds that are av8il#bJe for use 8t the Tru$t8e$' dIS¢ret in fvrlherance of the objo¢tives of the charity. Restricted funds are those donated for use in A p8rtkul8r area f0 a spteffic purposè. tho Uso of which is $trICt&d to that Area. Det8ils of th8 natur8 and purpos& of each fvnd is set out in nots 12. G¢)v•maneè ¢osts ())vernance costs include costs of the preparatlon and examlnation of the Report and FInaF81 Statement. (osts relattng to Trugtees. moetings and any18gal costs roFat6ng to gtsv8rnanc8 and conslitutK)nal m8ttars. 2. Tran¢tIOnS wlth Tn•Btees and other connected persons No transactions took place bethen the Trust and the Truslees or any persons connected with them. Page 10
E FRIENDS OF BRISTOL HAEMATOLOGY AND ONCOLOGY CENTRE TES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED DECEMBER 2023 Fixed •ss•t Inv•stments 2023 2022 Ltsted Inv•sthi•nts at markot value Fixgd intefest seCurftS Equfy shwes Investmerit trusts and unlt trusts 912.983 3,479.626 196.163 4,59LTr.772 12,268 4,603,(140 730,847 3.210,276 269,977 4,211.100 200,602 4,411,702 Cash Hl#torb¢al eost of Ilst8d Invostmont8 4.334,236 4,088,267 Listed invèstments Cash Total Mark&t value.. At 31 D8cember 2022 Additions 4,211,100 675,951 I4,987) 133,7(18 200,602 513,300 1675.951 4.411,702 1.189.251 11.105,9381 133,708 125,6831 Disposals Incrèasa in value in year Transfer to income 125,6831 At 31 December 2023 4,5.772 12,268 4.603,040 At 31 Decernber 2023 there r6 holdings with a mart(et value in èxeess of SYD of the totsl valve. A hokling of S&P I shares had a market value of £430,100 arKI a hokling ol Vanguard FTSE Developed Worfd had a market value of £336,877. , D•btors 2023 2022 PrepaT(l expen898 LegaCS due 1.549 30.000 1.549 30.0(X) Cr•dltors: amounts falling withln onè ar 2023 2022 A{rUed èxpenses UnpaMI invoices 7.528 9,180 7,528 9,180 Pago13
THE FRIENDS OF BRISTOL HAEMATOLOGY AND ONCOLOGY CENTRE NOTES TO THE FINANCIAL STATEMENfs FOR THE YEAR ENDED 31 DECEhlBER 20 12. Funds At31 D袕mb•r 2022 Transfern between funds At31 December 2023 Ineomlng RourceS expended R•$trfctsd Funds Equipfftent fund- to PUTthase and malnt8ln medical equipmgnt Rosearch Fund- to furvj resgarch projects Marsden bequest- io lund research salaries E8m)arked fund- grfts fo¥ other purposes 2,687 22,121 1.467 23,856 50,131 21,471 267 91.426 67,268 22,388 1.485 Y3.015 46,888 t8 5,247 27.003 6,088 97.514 67,268 Unr¢strlcted fvnds Gen8ral fund 5,054.396 5.104,527 411,505 438.508 88,819 186,333 {67,2681 5,309,814 5,356.702 1& Analysls of n•t as8•ts b•lwwn funds Unrestricied Funds Restricled Funds Tot81 Funds 2023 Invostrnents 4,603,040 714.302 17,5281 5.309.814 4,603,040 761,190 17,5281 5,356,702 Current assels 46,888 Cr8ditors du& within one ye 46,888 1L Approved futur• fvndlng At 31 Decembèr 2023 the lrnst had ont&r8d into Ihe followng funding commitments. Courses for hospftal staff Informatlon support research salaries Chefflotherapy trgalment chairs R8diotherapy planning trial F8tigu8 8pp devgloprnenl TfA ¢<)mplinenlary therap5 P8tient support videos Practitioner lor CART 11 therapy Immoiilisation boards 16,OCN) 26.0(X) 12,000 8,500 4.586 40,0 2,250 187,0(X) 9,528 3.228 5,5C(I 672.674 31.789 53.874 318,000 25,000 Decorating cancer support qUt r(%)m and d&1 trials room Pilot ECG lip syst&m Surface guid8(I r8diothèrapy system CardLqc monitor5 Auto OtlIn19 software 8rachythèrapy HDR Bariati¢ tr011gy Page 14
rHE FRIENDS OF BRISTOL HAEMATOLQGY AND ONCOLOGY CENTRE YOTES TO TrIE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2023 IS. Ro¢on¢lllation of net movemgnt in funds to ¢a$h flow from opgratlng •etl¥ltl•s 2023 2022 Net movemenl in funds Less inv8stment income Less10sslg8ins on investments Decreasellincr8asel in debtors {DecreaseIneas8 in creditors 252,175 1108,8221 1217,0211 28,451 11,6521 1243.5591 198.089) 373,568 128,9851 11.9381 Net cash generaied by oper8tlng act88 146,8691 997 Page 15